1. Home
  2. CLNE vs CGEM Comparison

CLNE vs CGEM Comparison

Compare CLNE & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNE
  • CGEM
  • Stock Information
  • Founded
  • CLNE 2001
  • CGEM 2016
  • Country
  • CLNE United States
  • CGEM United States
  • Employees
  • CLNE N/A
  • CGEM N/A
  • Industry
  • CLNE Natural Gas Distribution
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLNE Utilities
  • CGEM Health Care
  • Exchange
  • CLNE Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • CLNE 610.0M
  • CGEM 490.3M
  • IPO Year
  • CLNE 2007
  • CGEM 2021
  • Fundamental
  • Price
  • CLNE $1.87
  • CGEM $8.96
  • Analyst Decision
  • CLNE Strong Buy
  • CGEM Strong Buy
  • Analyst Count
  • CLNE 3
  • CGEM 4
  • Target Price
  • CLNE $4.33
  • CGEM $32.00
  • AVG Volume (30 Days)
  • CLNE 3.5M
  • CGEM 438.1K
  • Earning Date
  • CLNE 05-08-2025
  • CGEM 05-08-2025
  • Dividend Yield
  • CLNE N/A
  • CGEM N/A
  • EPS Growth
  • CLNE N/A
  • CGEM N/A
  • EPS
  • CLNE N/A
  • CGEM N/A
  • Revenue
  • CLNE $415,920,000.00
  • CGEM N/A
  • Revenue This Year
  • CLNE N/A
  • CGEM N/A
  • Revenue Next Year
  • CLNE $8.45
  • CGEM N/A
  • P/E Ratio
  • CLNE N/A
  • CGEM N/A
  • Revenue Growth
  • CLNE 4.85
  • CGEM N/A
  • 52 Week Low
  • CLNE $1.30
  • CGEM $6.85
  • 52 Week High
  • CLNE $3.67
  • CGEM $24.76
  • Technical
  • Relative Strength Index (RSI)
  • CLNE 55.23
  • CGEM 66.41
  • Support Level
  • CLNE $1.79
  • CGEM $7.73
  • Resistance Level
  • CLNE $1.93
  • CGEM $8.00
  • Average True Range (ATR)
  • CLNE 0.12
  • CGEM 0.51
  • MACD
  • CLNE -0.02
  • CGEM 0.15
  • Stochastic Oscillator
  • CLNE 47.37
  • CGEM 92.51

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas, and renewable natural gas as an alternative fuel for vehicles. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: